CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Network for Continuing Medical Education

Network for Continuing Medical Education is a Secaucus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aural Analytics

We build applications that use speech and fine motor to detect subtle changes in brain health. We are rooted in neuroscience with an award winning, first to market technology platform that turns the devices we use every day into objective brain health monitors.

Rocky Mountain Health Plans

Rocky Mountain Health Plans is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Grand Junction, CO. To find more information about Rocky Mountain Health Plans, please visit www.rmhp.org

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Montclair Park At Poulsbo

Montclair Park At Poulsbo is a Poulsbo, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.